1-2 of 2
alanine transaminase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis

Clinical Trials & Observations
Hyehyun Jeong, Hyungwoo Cho, Hyeyeong Kim, Heejung Chae, Jung-Bok Lee, Kyoungmin Lee, Shin Kim, Sang-wook Lee, Jin-Sook Ryu, Kyung Won Kim, Eun Jin Chae, Jooryung Huh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2142–2152.
https://doi.org/10.1182/bloodadvances.2020003947
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

Clinical Trials & Observations
Jeffrey E. Lancet, Anna B. Moseley, Steven E. Coutre, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1683–1689.
https://doi.org/10.1182/bloodadvances.2019001278
Published: 2020